CClinicalTrials.gg
Status unknownNCT04956497ECPR-ChinaUpdated Jul 9, 2021

Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China

An observational study in Extracorporeal Membrane Oxygenation Complication and Cardiopulmonary Arrest, sponsored by Peking Union Medical College Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-07-09.

Sponsored by Peking Union Medical College Hospital · Observational

The sponsor has not verified this record recently (last verified May 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

The data of patients undergo extracorporeal cardiopulmonary resuscitation (eCPR) will be collected and analyzed. This study will provide useful information about the indication, the start time and others to improve the outcome of ECPR.

02

Conditions studied

  • Extracorporeal Membrane Oxygenation Complication
  • Cardiopulmonary Arrest

Browse trials for

03

In context

Heart Arrest

966 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

This study's planned enrollment of 300 is above the median of 200 across 383 observational studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

Peking Union Medical College Hospital is the lead sponsor of 1,115 studies on the registry; 463 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All adult (age>=18y) cardiac arrested patients accept ECPR treatment will be enrolled in the study.

Inclusion criteria

  • Age >=18y
  • Cardiac arrested patients accept ECPR treatment

Exclusion criteria

Exclusion Criteria:

  • No
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
300 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes

Interventions

  • Deviceextracorporeal membrane oxygenation (ECMO)

    ECMO under ongoing cardiopulmonary resuscitation (eCPR) in patients with refractory cardiac arrest

06

What researchers measure

Primary outcomes

  1. mortality rate

    the death rate of the patients

    Time frame: 28 days

07

Study locations

1 site
  • Peking Union Medical College Hospital
    Beijing, 100730, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04956497
Lead sponsor
Peking Union Medical College Hospital
Responsible party
Sponsor
First posted
Jul 9, 2021
Start date
Sep 1, 2021 (estimated)
Primary completion
Oct 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Jul 9, 2021

Study contacts

Jun Xu, MD
Contact
xunjunfree@126.com
15801578819
Jun Xu, MD
study chair · Peking Union Medical College Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion